BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Enkner F, Pichlhöfer B, Zaharie AT, Krunic M, Holper TM, Janik S, Moser B, Schlangen K, Neudert B, Walter K, Migschitz B, Müllauer L. Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic Targets. Pathol Oncol Res 2017;23:551-64. [PMID: 27844328 DOI: 10.1007/s12253-016-0144-8] [Cited by in Crossref: 32] [Cited by in F6Publishing: 38] [Article Influence: 6.4] [Reference Citation Analysis]
Number Citing Articles
1 Chen HF, Wu LX, Li XF, Zhu YC, Pan WW, Wang WX, Xu CW, Huang JH, Wu MH, Du KQ. PD-L1 expression level in different thymoma stages and thymic carcinoma: a meta-analysis. Tumori 2020;106:306-11. [PMID: 32366210 DOI: 10.1177/0300891620915788] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Marx A, Belharazem D, Lee DH, Popovic ZV, Reißfelder C, Schalke B, Schölch S, Ströbel P, Weis CA, Yamada Y. Molecular pathology of thymomas: implications for diagnosis and therapy. Virchows Arch 2021;478:101-10. [PMID: 33674910 DOI: 10.1007/s00428-021-03068-8] [Reference Citation Analysis]
3 Vaideeswar P. The thymoma tale. Indian J Med Res 2019;150:110-1. [PMID: 31670265 DOI: 10.4103/ijmr.IJMR_155_19] [Reference Citation Analysis]
4 Asselta R, Di Tommaso L, Perrino M, Destro A, Giordano L, Cardamone G, Rubino L, Santoro A, Duga S, Zucali PA. Mutation profile and immunoscore signature in thymic carcinomas: An exploratory study and review of the literature. Thorac Cancer 2021;12:1271-8. [PMID: 33704917 DOI: 10.1111/1759-7714.13765] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Oberndorfer F, Müllauer L. Genomic alterations in thymoma-molecular pathogenesis? J Thorac Dis 2020;12:7536-44. [PMID: 33447444 DOI: 10.21037/jtd.2019.12.52] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
6 Wood K, Byron E, Janisch L, Salgia R, Sharma MR. Capecitabine and Celecoxib as a Promising Therapy for Thymic Neoplasms. Am J Clin Oncol 2018;41:963-6. [PMID: 28654574 DOI: 10.1097/COC.0000000000000400] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
7 Liao X, Zhu G, Huang R, Yang C, Wang X, Huang K, Yu T, Han C, Su H, Peng T. Identification of potential prognostic microRNA biomarkers for predicting survival in patients with hepatocellular carcinoma. Cancer Manag Res 2018;10:787-803. [PMID: 29713196 DOI: 10.2147/CMAR.S161334] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
8 Soomro IN. Pathology of thymoma-where are we today? J Thorac Dis 2020;12:7545-52. [PMID: 33447445 DOI: 10.21037/jtd-2019-thym-04] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Xu S, Li X, Zhang H, Zu L, Yang L, Shi T, Zhu S, Lei X, Song Z, Chen J. Frequent Genetic Alterations and Their Clinical Significance in Patients With Thymic Epithelial Tumors. Front Oncol 2021;11:667148. [PMID: 34307137 DOI: 10.3389/fonc.2021.667148] [Reference Citation Analysis]
10 Guleria P, Husain N, Shukla S, Kumar S, Parshad R, Jain D. PD-L1 immuno-expression assay in thymomas: Study of 84 cases and review of literature. Ann Diagn Pathol 2018;34:135-41. [PMID: 29661720 DOI: 10.1016/j.anndiagpath.2018.03.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
11 Tateo V, Manuzzi L, Parisi C, De Giglio A, Campana D, Pantaleo MA, Lamberti G. An Overview on Molecular Characterization of Thymic Tumors: Old and New Targets for Clinical Advances. Pharmaceuticals (Basel) 2021;14:316. [PMID: 33915954 DOI: 10.3390/ph14040316] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Conforti F, Pala L, Giaccone G, De Pas T. Thymic epithelial tumors: From biology to treatment. Cancer Treat Rev 2020;86:102014. [PMID: 32272379 DOI: 10.1016/j.ctrv.2020.102014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
13 Chen K, Che J, Zhang X, Jin R, Xiang J, Han D, Sun Y, Gong Z, Zhang D, Li H. Next-generation sequencing in thymic epithelial tumors uncovered novel genomic aberration sites and strong correlation between TMB and MSH6 single nucleotide variations. Cancer Lett 2020;476:75-86. [PMID: 32061754 DOI: 10.1016/j.canlet.2020.02.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Hellyer JA, Ouseph MM, Padda SK, Wakelee HA. Everolimus in the treatment of metastatic thymic epithelial tumors. Lung Cancer 2020;149:97-102. [PMID: 33007678 DOI: 10.1016/j.lungcan.2020.09.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
15 Rai M, Keogh A. A Rare Case of a High-Grade Thymic Squamous Cell Carcinoma Presenting as Cardiac Tamponade. Cureus 2020;12:e9366. [PMID: 32850235 DOI: 10.7759/cureus.9366] [Reference Citation Analysis]
16 Liang N, Liu L, Huang C, Liu H, Guo C, Li J, Wang W, Li N, Lin R, Wang T, Ding L, Mao L, Li S. Transcriptomic and Mutational Analysis Discovering Distinct Molecular Characteristics Among Chinese Thymic Epithelial Tumor Patients. Front Oncol 2021;11:647512. [PMID: 34568003 DOI: 10.3389/fonc.2021.647512] [Reference Citation Analysis]
17 Gbolahan OB, Porter RF, Salter JT, Yiannoutsos C, Burns M, Chiorean EG, Loehrer PJ Sr. A Phase II Study of Pemetrexed in Patients with Recurrent Thymoma and Thymic Carcinoma. J Thorac Oncol 2018;13:1940-8. [PMID: 30121390 DOI: 10.1016/j.jtho.2018.07.094] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
18 Marx A, Chan JKC, Chalabreysse L, Dacic S, Detterbeck F, French CA, Hornick JL, Inagaki H, Jain D, Lazar AJ, Marino M, Marom EM, Moreira AL, Nicholson AG, Noguchi M, Nonaka D, Papotti M, Porubsky S, Sholl LM, Tateyama H, Thomas de Montpréville V, Travis WD, Rajan A, Roden AC, Ströbel P. The 2021 World Health Organization Classification of Tumors of the Thymus and Mediastinum: What's new in thymic epithelial, germ cell and mesenchymal tumors? J Thorac Oncol 2021:S1556-0864(21)03258-5. [PMID: 34695605 DOI: 10.1016/j.jtho.2021.10.010] [Reference Citation Analysis]
19 Jovanovic D, Markovic J, Ceriman V, Peric J, Pavlovic S, Soldatovic I. Correlation of genomic alterations and PD-L1 expression in thymoma. J Thorac Dis 2020;12:7561-70. [PMID: 33447447 DOI: 10.21037/jtd-2019-thym-13] [Reference Citation Analysis]
20 Rajan A, Mullenix C, Shelat M, Zhao C. The role of immunotherapy for management of advanced thymic epithelial tumors: a narrative review. Mediastinum 2021;5:23. [PMID: 34541456 DOI: 10.21037/med-20-62] [Reference Citation Analysis]
21 Sakane T, Murase T, Okuda K, Saida K, Masaki A, Yamada T, Saito Y, Nakanishi R, Inagaki H. A mutation analysis of the EGFR pathway genes, RAS, EGFR, PIK3CA, AKT1 and BRAF, and TP53 gene in thymic carcinoma and thymoma type A/B3. Histopathology 2019;75:755-66. [PMID: 31179560 DOI: 10.1111/his.13936] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
22 Vargas AC, Gray LA, White CL, Maclean FM, Grimison P, Ardakani NM, Bonar F, Algar EM, Cheah AL, Russell P, Mahar A, Gill AJ. Genome wide methylation profiling of selected matched soft tissue sarcomas identifies methylation changes in metastatic and recurrent disease. Sci Rep 2021;11:667. [PMID: 33436720 DOI: 10.1038/s41598-020-79648-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Sakane T, Sakamoto Y, Masaki A, Murase T, Okuda K, Nakanishi R, Inagaki H. Mutation Profile of Thymic Carcinoma and Thymic Neuroendocrine Tumor by Targeted Next-generation Sequencing. Clin Lung Cancer 2021;22:92-99.e4. [PMID: 33414055 DOI: 10.1016/j.cllc.2020.11.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Feng Y, Lei Y, Wu X, Huang Y, Rao H, Zhang Y, Wang F. GTF2I mutation frequently occurs in more indolent thymic epithelial tumors and predicts better prognosis. Lung Cancer 2017;110:48-52. [PMID: 28676218 DOI: 10.1016/j.lungcan.2017.05.020] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
25 Pandey D, Shepro DS. Thymic cancer in lynch syndrome: an unusual association. BMJ Case Rep 2020;13:e230241. [PMID: 32273268 DOI: 10.1136/bcr-2019-230241] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Ishihara S, Okada S, Ogi H, Kodama Y, Shimomura M, Tsunezuka H, Itoh K, Marx A, Inoue M. Programmed death-ligand 1 expression profiling in thymic epithelial cell tumors: Clinicopathological features and quantitative digital image analyses. Lung Cancer 2020;145:40-7. [PMID: 32402921 DOI: 10.1016/j.lungcan.2020.04.038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Wolf JL, van Nederveen F, Blaauwgeers H, Marx A, Nicholson AG, Roden AC, Ströbel P, Timens W, Weissferdt A, von der Thüsen J, den Bakker MA. Interobserver variation in the classification of thymic lesions including biopsies and resection specimens in an international digital microscopy panel. Histopathology 2020;77:734-41. [PMID: 32506527 DOI: 10.1111/his.14167] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Jain D, Guleria P, Singh V, Parshad R, Kumar S, Gaiser T, Kurz KS, Ott G, Porubsky S, Preissler G, Sauer CG, Schölch S, Ströbel P, Hielscher T, Marx A, Popovic ZV. GTF2I Mutation in Thymomas: Independence From Racial-Ethnic Backgrounds. An Indian/German Comparative Study. Pathol Oncol Res 2021;27:1609858. [PMID: 34497477 DOI: 10.3389/pore.2021.1609858] [Reference Citation Analysis]
29 Higuchi R, Goto T, Hirotsu Y, Nakagomi T, Yokoyama Y, Otake S, Amemiya K, Oyama T, Omata M. PD-L1 Expression and Tumor-Infiltrating Lymphocytes in Thymic Epithelial Neoplasms. J Clin Med 2019;8:E1833. [PMID: 31683962 DOI: 10.3390/jcm8111833] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
30 Liu D, Zhang P, Zhao J, Yang L, Wang W. Identification of Molecular Characteristics and New Prognostic Targets for Thymoma by Multiomics Analysis. Biomed Res Int 2021;2021:5587441. [PMID: 34104648 DOI: 10.1155/2021/5587441] [Reference Citation Analysis]
31 Rajan A, Zhao C. Deciphering the biology of thymic epithelial tumors. Mediastinum 2019;3:36. [PMID: 31608319 DOI: 10.21037/med.2019.08.03] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
32 Janik S, Bekos C, Hacker P, Raunegger T, Ghanim B, Einwallner E, Beer L, Klepetko W, Müllauer L, Ankersmit HJ, Moser B. Elevated CRP levels predict poor outcome and tumor recurrence in patients with thymic epithelial tumors: A pro- and retrospective analysis. Oncotarget 2017;8:47090-102. [PMID: 28514756 DOI: 10.18632/oncotarget.17478] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
33 Roden AC, Szolkowska M. Common and rare carcinomas of the thymus. Virchows Arch 2021;478:111-28. [PMID: 33389148 DOI: 10.1007/s00428-020-03000-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Soejima S, Kondo K, Tsuboi M, Muguruma K, Tegshee B, Kawakami Y, Kajiura K, Kawakita N, Toba H, Yoshida M, Takizawa H, Tangoku A. GAD1 expression and its methylation as indicators of malignant behavior in thymic epithelial tumors. Oncol Lett 2021;21:483. [PMID: 33968199 DOI: 10.3892/ol.2021.12744] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Wang J, Huang H, Zhang X, Ma H. LOXL1‑AS1 promotes thymoma and thymic carcinoma progression by regulating miR‑525‑5p‑HSPA9. Oncol Rep 2021;45:117. [PMID: 33907842 DOI: 10.3892/or.2021.8068] [Reference Citation Analysis]
36 Principe DR, Kamath SD, Munshi HG, Mohindra NA. Metastatic Thymoma Harboring a Deleterious BRCA2 Mutation Derives Durable Clinical Benefit from Olaparib. Oncologist 2020;25:301-5. [PMID: 32297440 DOI: 10.1634/theoncologist.2019-0393] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Meng FJ, Wang S, Zhang J, Yan YJ, Wang CY, Yang CR, Guan ZY, Wang CL. Alteration in gene expression profiles of thymoma: Genetic differences and potential novel targets. Thorac Cancer 2019;10:1129-35. [PMID: 30932350 DOI: 10.1111/1759-7714.13053] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
38 Pandey SK, Yadav S, Goel Y, Singh SM. Cytotoxic action of acetate on tumor cells of thymic origin: Role of MCT-1, pH homeostasis and altered cell survival regulation. Biochimie 2019;157:1-9. [DOI: 10.1016/j.biochi.2018.10.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]